Can nifedipine extended‑release 90 mg be given twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nifedipine ER 90 mg Should Be Given Once Daily, Not Twice Daily

Nifedipine extended-release 90 mg is designed for once-daily administration and should not be split into twice-daily dosing. 1

FDA-Approved Dosing Schedule

  • The FDA label explicitly states that nifedipine extended-release tablets should be administered once daily on an empty stomach 1
  • The usual maintenance dose range is 30-60 mg once daily, with titration up to 90 mg once daily permitted 1
  • Doses above 90 mg daily are not recommended by the FDA 1

Guideline-Based Recommendations

  • The ACC/AHA guidelines specify nifedipine LA (long-acting) at 30-90 mg once daily as the standard dosing frequency for hypertension 2
  • Multiple clinical guidelines consistently recommend extended-release nifedipine be dosed once daily to maintain stable therapeutic plasma concentrations over 24 hours 3, 4
  • The extended-release formulation is specifically engineered to maintain therapeutic blood levels for approximately 24 hours with single daily dosing 3

Why Not Twice Daily?

  • Formulation design: Extended-release nifedipine tablets are designed as intact delivery systems that must be swallowed whole and cannot be divided 1
  • Pharmacokinetic profile: The ER formulation provides controlled drug release over 24 hours, making twice-daily dosing unnecessary and potentially leading to inappropriate peak-trough variations 3
  • Clinical evidence: Studies demonstrate that once-daily ER formulations provide superior persistence and compliance compared to twice-daily formulations, with patients on once-daily dosing showing 1.3 times better persistence 5

Important Clinical Caveats

  • If blood pressure control is inadequate at 90 mg once daily, consider adding a second antihypertensive agent from a different class rather than splitting the dose or exceeding 90 mg 2, 1
  • Never confuse formulations: Immediate-release nifedipine requires multiple daily doses but should be avoided entirely due to safety concerns unless given with beta-blockade 3, 4
  • Slow-release (retard) formulations that require twice-daily dosing are different products than the extended-release 24-hour formulation 6, 5

Practical Algorithm

  1. Start: Nifedipine ER 30 mg once daily 1
  2. Titrate: Increase to 60 mg once daily after 7-14 days if needed 1
  3. Maximum monotherapy: 90 mg once daily 1
  4. If inadequate control: Add second agent (ACE inhibitor, ARB, or thiazide diuretic) rather than exceeding 90 mg or splitting doses 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nifedipine Dosing Guidelines for Hypertension and Angina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Nifedipine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.